Search - tctmd.com

Displaying 1 - 20 of 63

Sort: Relevancy | Date

Presentation NY Valves 2025

Early Bioprosthetic Valve Dysfunction Treated With Urgent Redo TAVI: Acurate Neo2 in Sapien 3

Presenter: Thiago Abizaid

June 26, 2025

Presentation NY Valves 2025

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Presenter: Chloe Kharsa

June 26, 2025

Presentation Miami Valves 2025

Initial Experience with the Acurate Neo2 TAVR in the Dominican Republic

Presenter: Karla Marie Garcia Almonte

January 30, 2025

Presentation Miami Valves 2025

Selected Case of CE Approved TAVR Valve: Acurate Neo2

Presenter: Fábio S. Brito Jr.

January 30, 2025

Presentation TCT 2024

ACURATE IDE Insights: Optimizing Clinical Implants

Presenter: NULL

October 30, 2024

Presentation TCT 2024

Summary and Next Steps

Presenter: NULL

October 30, 2024

Presentation TCT 2024

A Closer Look at the ACURATE IDE Study

Presenter: NULL

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

Recent EU Clinical Experiences with the ACURATE TAVR System

Presenter: Ole De Backer

October 28, 2024

Presentation TCT 2024

ACURATE Fundamentals: What You Need to Know

Presenter: Srini Potluri

October 28, 2024

Presentation TCT 2024

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Presenter: Ignacio Amat-Santos

October 28, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement

Presenter: Jonathan Michel

June 07, 2024

Presentation NY Valves 2024

Understanding the Fundamentals of the ACURATE Platform

Presenter: Isaac George

June 05, 2024

Presentation TCT 2023

TCT 261: Review of Short-term Outcomes of ACURATE neo2

Presenter: Akihiro Tobe

October 26, 2023

Presentation TCT 2023

ACURATE Case in a Box

Presenter: Ravi Ramana

October 25, 2023

Presentation TCT 2023

ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies

Presenter: Pradeep Yadav

October 25, 2023

Presentation TCT 2023

TCT 474: ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)

Presenter: Ahmed Elkoumy

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TVT 2023

Clinical Data for the ACURATE Platform

Presenter: Ole De Backer

June 08, 2023

Advertisement

Early Bioprosthetic Valve Dysfunction Treated With Urgent Redo TAVI: Acurate Neo2 in Sapien 3

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Initial Experience with the Acurate Neo2 TAVR in the Dominican Republic

Selected Case of CE Approved TAVR Valve: Acurate Neo2

ACURATE IDE Insights: Optimizing Clinical Implants

Summary and Next Steps

A Closer Look at the ACURATE IDE Study

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Recent EU Clinical Experiences with the ACURATE TAVR System

ACURATE Fundamentals: What You Need to Know

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement

Understanding the Fundamentals of the ACURATE Platform

TCT 261: Review of Short-term Outcomes of ACURATE neo2

ACURATE Case in a Box

ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies

TCT 474: ACURATE neo2 Implantation Without Balloon Predilatation (Direct ACURATE neo2)

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Clinical Data for the ACURATE Platform

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content